Among the thirteen different TLRs that have been described in mammals, only TLR2, TLR4, TLR5, and TLR9 have been documented to clearly associate with NAFLD pathogenesis and progression [69–74]. The gene discussed is TLR9; the disease is metabolic dysfunction-associated steatotic liver disease.